PYM
Creates natural supplements with science-backed ingredients to boost mood and neurotransmitter health.
Website: https://youcanpym.com
Cover Block
| Field | Value |
|---|---|
| Name | PYM (Prepare Your Mind) |
| Tagline | Natural supplements with science-backed ingredients to support mood and neurotransmitter health |
| Headquarters | Los Angeles, California |
| Founded | 2018 |
| Stage | Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech (mental wellness / supplements) |
| Technology Type | Biotech / Life Sciences |
| Geography | North America |
| Founding Team | Co-Founders (2): Zak Williams, Olivia June |
| Funding Label | Seed |
| Total Disclosed | ~$1,000,000 [Inc] |
Links
- Website: https://youcanpym.com/
- LinkedIn: https://www.linkedin.com/company/pyminc
- Lead investor portfolio listing: https://adaptvc.com/companies
Summary and Signal
PYM is a Los Angeles-based direct-to-consumer mental wellness brand selling amino-acid-based chewables positioned as a daily support tool for mood and stress, founded in 2018 by Zak Williams and Olivia June [Crunchbase]. The company sits at an intersection that has drawn meaningful consumer attention: the destigmatization of mental health, the mainstreaming of nutraceuticals, and a generation of consumers willing to try non-prescription alternatives before, or alongside, clinical care. Zak Williams launched the company after the 2014 death of his father, the actor Robin Williams, and has built much of PYM's public identity around mental health advocacy [Fortune, 2023]. The product line centers on "Mood Chews" formulated with amino acids, vitamins, and minerals intended to support neurotransmitter pathways [LinkedIn]. The disclosed capitalization is roughly $1 million [Inc], with Adapt VC named among backers [Adapt VC]. The founding team pairs a CEO with a Columbia MBA and an entertainment-industry network [Crunchbase] [The Org] with a co-founder who previously built community and studio programs at RocketSpace and founded VINA [Crunchbase]. Over the next 12 to 18 months, the variables most worth watching are SKU expansion, retail distribution beyond the DTC site, and whether PYM converts founder-led media reach into repeat purchase economics that justify a priced equity round.
Data Accuracy: YELLOW -- Founding details and funding figure corroborated by Crunchbase, Inc., and Fortune; growth metrics not publicly disclosed.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | Direct-to-Consumer |
| Industry / Vertical | Healthtech, mental wellness supplements |
| Technology Type | Biotech / Life Sciences (nutraceutical formulation) |
| Geography | North America |
| Founding Team | Two co-founders (spousal team) |
| Funding | ~$1M disclosed, Seed |
Company Overview
PYM, short for "Prepare Your Mind," was founded in 2018 in Los Angeles by Zak Williams and Olivia June [Crunchbase]. Williams has spoken publicly about building the company in response to his own struggles with anxiety and depression following his father Robin Williams's death in 2014, and has framed PYM as part of a broader personal commitment to mental health advocacy [Fortune, 2023]. Olivia June, who is married to Williams and previously founded the friendship app VINA, collaborated on the early formulation work after her own experience with mood regulation through amino acid therapy [PYM Website] [Crunchbase].
The company has stayed deliberately narrow on product surface area. Its flagship is a chewable supplement marketed under the "Mood Chews" line, sold through the youcanpym.com storefront and reviewed in consumer-facing outlets such as Honest Brand Reviews and The Quality Edit [Honest Brand Reviews] [The Quality Edit]. Williams has used speaking platforms, including Fortune's Brainstorm Health conference, to discuss the company's positioning at the intersection of consumer wellness and mental health [Fortune, 2023].
Publicly identified milestones are limited. Inc. reported a roughly $1 million raise tied to a new product launch [Inc], and Adapt VC lists PYM in its portfolio [Adapt VC]. Beyond that, the company has not disclosed revenue, unit volume, retail partnerships, or subsequent priced rounds in the captured public record.
Data Accuracy: YELLOW -- Founding story and team confirmed by Fortune, Crunchbase, and the company website; corporate registration details not in the public record.
The Product and the Stack
PYM's product is a consumer supplement, not a software platform. The company describes its chews as built around amino acids, vitamins, and minerals selected to support neurotransmitter health [LinkedIn]. Crunchbase characterizes PYM as working with "neuroscientists and nutritional psychiatrists" to develop a "personal mental hygiene solution" [Crunchbase].
Third-party consumer reviews provide the clearest external read on the product experience. Honest Brand Reviews and The Quality Edit both cover the Mood Chews format, packaging, and taste, and describe the product as an over-the-counter daily-use chew rather than a clinical intervention [Honest Brand Reviews] [The Quality Edit]. The product is regulated in the United States as a dietary supplement, which means it is not subject to FDA pre-market efficacy review.
No proprietary delivery technology, patent filing, or manufacturing facility has been disclosed in the captured sources. Investors evaluating the technology layer should treat the differentiation as resting on brand, founder narrative, and ingredient curation rather than on defensible IP.
Data Accuracy: ORANGE -- Product description corroborated by company site, LinkedIn, and two consumer review outlets; formulation IP and manufacturing partners not publicly disclosed.
Market Research and Opportunity
United States adults reporting symptoms of anxiety or depression climbed sharply during and after the pandemic, and over-the-counter mood and stress products have become one of the fastest-growing shelf categories in mass and natural retail.
The demand drivers most relevant to PYM are three. First, destigmatization: Williams's own public advocacy is one example of a broader cultural shift in which discussing mood and anxiety has moved into mainstream consumer conversation [Fortune, 2023]. Second, the bottleneck in clinical access: wait times for therapists and psychiatrists in major U.S. metros routinely run weeks to months, which has pushed consumers toward self-directed, lower-friction options. Third, the maturation of the functional supplements category, where amino acid blends, adaptogens, and nootropics have moved from niche retailers into Whole Foods, Target, and Amazon's main supplement aisles.
Adjacent and substitute markets matter for how PYM is valued. On one side sit telehealth-prescribed mental health platforms (Cerebral, Talkiatry, Hims & Hers Mental Health), which compete for the same consumer attention but address a more clinically severe segment. On the other side sit pure consumer brands in functional wellness (Olly, Calm-branded gummies, Moon Juice, Recess) that compete directly for shelf space and consumer trial.
Regulatory posture is the macro variable most likely to reshape the category. The FDA has signaled increasing scrutiny of supplement marketing claims that edge into disease treatment language, and class-action litigation around "mood" and "stress" claims has risen. PYM's public messaging has stayed on the wellness side of that line in the materials reviewed [PYM Website] [Honest Brand Reviews].
| Metric | Value |
|---|---|
| PYM disclosed capital raised | $1,000,000 |
Data Accuracy: ORANGE -- Category context is analyst commentary; the only PYM-specific number is the Inc.-reported raise.
The Competitive Field
PYM competes in a crowded consumer wellness shelf where brand, founder narrative, and retail distribution matter more than formulation novelty.
The segment can be mapped into three groups. The first is mass-market functional supplement brands such as Olly, Natrol, and the Calm-branded gummy line. The second is venture-backed DTC wellness brands that have built around a specific use case and a strong founder voice, including Recess, Moon Juice, and Apothékary. The third is the telehealth-and-prescription cohort, including Hims & Hers's mental health line and Cerebral.
Where PYM has a defensible edge today, it is on narrative and earned media rather than on distribution or IP. Founder-led press in Fortune, Inc., and the San Francisco Chronicle gives the brand a story that is genuinely difficult to replicate, and Williams's mental health advocacy work compounds that asset every time he speaks publicly [Fortune, 2023] [Inc] [San Francisco Chronicle].
Where PYM is most exposed is on capital and distribution. A roughly $1 million disclosed raise [Inc] is a fraction of what Olly, Recess, or Hims have deployed against the same consumer. The most plausible 18-month scenario splits along that axis. Winner if PYM secures a national specialty retail partner and uses that to anchor a priced Series A. Loser if the category's larger players launch a competing "mood chew" SKU and out-merchandise PYM at point of sale.
Data Accuracy: ORANGE -- Competitor set is analyst-identified from the broader category; no head-to-head share data is publicly disclosed for PYM.
Opportunity
If PYM executes, the prize is becoming the default consumer brand for everyday mental wellness.
The headline opportunity is that PYM becomes the Olly of mental wellness: a recognizable, multi-SKU, mass-distributed consumer brand specifically associated with mood and stress support, sold across DTC, Amazon, and national specialty and grocery retail. Two reasons make that outcome reachable: the founder has demonstrable, repeatable access to top-tier consumer and business press on a topic he is personally credible discussing [Fortune, 2023] [Inc] [San Francisco Chronicle], and the product format is one that has historically traveled well from DTC into mass retail.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Specialty retail breakout | PYM lands a national specialty grocery or beauty rollout and uses sell-through data to raise a priced Series A | A merchandising buyer commits to a chain-wide planogram set | Founder media reach and category tailwinds in mood support are documented [Fortune, 2023] |
| Strategic acquisition | A consumer health incumbent acquires PYM to enter the mental wellness shelf | A category-defining quarter of DTC growth or a retail data point that signals category leadership | Olly's 2019 acquisition by Unilever established the playbook for incumbents buying functional-wellness DTC brands |
| Platform brand expansion | PYM extends from chews into adjacent SKUs and becomes a multi-product mental wellness house brand | A successful second-product launch with retained DTC subscribers | Adapt VC's portfolio thesis backs consumer brands building beyond a single SKU [Adapt VC] |
Data Accuracy: YELLOW -- Scenarios are analyst-constructed from category comparables; only the founder media footprint and disclosed raise are directly evidenced in the cited sources.
Sources
- [Crunchbase] PYM - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/pym
- [Crunchbase] Zak Williams - Co-Founder and CEO @ PYM | https://www.crunchbase.com/person/zak-williams
- [LinkedIn] PYM | LinkedIn | https://www.linkedin.com/company/pyminc
- [Fortune, 2023] Robin Williams's son is dedicating his life to improving mental health | https://fortune.com/well/2023/05/01/robin-williams-son-zak-williams-mental-health-journey/
- [Fortune, 2023] Brainstorm Health 2023 - Prepare Your Mind: The Journey To Launch A Mental Health Startup | https://fortune.com/videos/watch/brainstorm-health-2023---prepare-your-mind:-the-journey-to-launch-a-mental-health-startup-/475e0eaf-43a4-4ab4-a6b7-22ee7e10bd71
- [San Francisco Chronicle] Robin Williams' son teams up with S.F. startup to use AI as mental health resource | https://www.sfchronicle.com/entertainment/article/robin-zak-williams-21309661.php
- [Substack] Interview with Zak Williams, CEO and Co-Founder of Prepare Your Mind | https://cluesdotlife.substack.com/p/interview-with-zak-williams-ceo-and
- [Honest Brand Reviews] PYM Mood Chews Review | https://www.honestbrandreviews.com/reviews/pym-mood-chews-review/
- [PYM] Our Story | https://youcanpym.com/pages/our-story
- [The Quality Edit] PYM Mood Chew Review | https://www.thequalityedit.com/articles/pym-mood-chew-review
- [PYM] PYM (Prepare Your Mind) storefront | https://youcanpym.com/
- [Inc] Robin Williams's Son Zak Battled Depression Too. Now His Mental Health Startup Has a New Product and $1 Million | https://www.inc.com/lindsay-blakely/zak-williams-pym-mental-health-wellness-startup.html
- [Adapt VC] A distinctive portfolio | https://adaptvc.com/companies
- [The Org] Zak Williams profile | https://theorg.com/
- [Milken Institute] Zak Williams speaker profile | https://milkeninstitute.org/
Articles about PYM
- PYM Is Betting Amino Acid Chews Can Sit Next to the Antidepressant — Zak Williams's Los Angeles supplement company is courting adults with everyday mood and anxiety symptoms, with $1M in seed capital and a DTC wedge.